doi:10.19983/j.issn.2096-8493.2024052

Abstract

CLC Number:

References 23

[1]	舒薇, 刘宇红. 世界卫生组织《2023年全球结核病报告》解读. 结核与肺部疾病杂志, 2024, 5(1):15-19. doi:10.19983/j.issn.2096-8493.2024006.
[2]	王家祥, 苟建军, 赵菁. 综合医院多学科协作在疾病诊治中的实践与作用. 医学与哲学, 2015, 36(9B):1-4.
[3]	卢水华. 关注结核病共患病已成为公共卫生的需要. 结核与肺部疾病杂志, 2022, 3(4):255-260. doi:10.19983/j.issn.2096-8493.20220107.
[4]	Huang Z, LaCourse SM, Kay AW, et al. CRISPR detection of circulating cell-free Mycobacterium tuberculosis DNA in adults and children,including children with HIV: a molecular diagnostics study. Lancet Microbe, 2022, 3(7): e482 -e492.doi:10.1016/S26665247(22) 00087-8.
[5]	舒薇, 刘宇红. 精进臻善惟实励新:世界卫生组织《2022年全球结核病报告》解读. 中国防痨杂志, 2023, 45(5):454-457. doi:10.19982/j.issn.1000-6621.20230102.
[6]	王瑾, 卢水华. 结核病学科建设:从临床资源型向医学科研型转化. 中国防痨杂志, 2023, 45(12):1125-1130. doi:10.19982/j.issn.1000-6621.20230353.
[7]	Wallis RS, Ginindza S, Beattie T, et al. Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective,open-label,phase 2,randomised controlled trial. Lancet Respir Med, 2021, 9 (8):897-908. doi:10.1016/S2213-2600(20) 30448-3.
[8]	董佳欣, 赵爱华, 夏焕章, 等. 《世界卫生组织新型结核病疫苗首选产品特性》的解读与思考. 中国防痨杂志, 2023, 45(11):1016-1020. doi:10.19982/j.issn.1000-6621.20230318.
[9]	Liu Q, Li W, Xue M, et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis:a meta-analysis. Sci Rep, 2017, 7(1):1090. doi:10.1038/s41598-017-01213-5.
[10]	Leung CC, Yew WW, Mok TYW, et al. Effects of diabetes mellitus on the clinical presentation and treatment response in tuberculosis. Respirology, 2017, 22(6):1225-1232. doi:10.1111/resp.13017. pmid: 28244689
[11]	林岩, 邓国防. 糖尿病并发结核病治疗中多学科合作应注意的问题. 中国防痨杂志, 2021, 43(7):649-652. doi:10.3969/j.issn.1000-6621.2021.07.002.
[12]	国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 国家代谢性疾病临床医学研究中心, 等. 结核病与糖尿病共病的治疗管理专家共识. 中国防痨杂志, 2021, 43(1): 12-22. doi:10.3969/j.issn.1000-6621.2021.01.004.
[13]	Huang CC, Chu AL, Becerra MC, et al. Mycobacterium tuberculosis Beijing Lineage and Risk for Tuberculosis in Child Household Contacts, Peru. Emerg Infect Dis, 2020, 26(3):568-578. doi:10.3201/eid2603.191314.
[14]	牛海军, 李远春, 赵雁林, 等. 河南省南阳市276例非结核分枝杆菌肺病的临床特征及其耐药性分析. 疾病监测, 2021, 36(7):708-713. doi:10.3784/jbjc.202101290055.
[15]	Özen N, Kula Atik T, Çetin Duran A. Klinik Örneklerden İzole Edilen Mycobacterium tuberculosis Kültür ve İlaç Duyarlılık Test Sonuçlarının Analizi ve Tüberküloz Dışı Mikobakterilerin Dagˇılımının İncelenmesi [Evaluation of Mycobacterium tuberculosis Culture and Drug Susceptibility Test Results and the Distribution of Nontuberculosis Mycobacteria from the Clinical Specimens]. Mikrobiyol Bul, 2020,54(4):559-574. Turkish. doi:10.5578/mb.70088.
[16]	王晨倩, 王桂荣, 姜广路, 等. 鸟分枝杆菌复合群对氯法齐明、贝达喹啉和德拉马尼的药物敏感性. 实用医学杂志, 2022, 38(6):691-695. doi:10.3969/j.issn.1006-5725.2022.06.008.
[17]	Bagcchi S. WHO’s Global Tuberculosis Report 2022. Lancet Microbe, 2023, 4(1):e20. doi:10.1016/S2666-5247(22)00359-7.
[18]	Qi TK, Chen J, Zhang RF, et al. A retrospective cohort study of early mortality among patients with HIV/TB co-infection in Shanghai municipality. HIV Med, 2020, 21(11):739-746. doi:10.1111/hiv.13025. pmid: 33369033
[19]	吴雪韵, 沈银忠. 人类免疫缺陷病毒与结核分枝杆菌合并感染发病机制的研究进展. 内科理论与实践, 2019, 14(4):253-258. doi:10.16138/j.1673-6087.2019.04.011.
[20]	中华医学会感染病学分会艾滋病丙型肝炎学组,中国疾病预防控制中心. 中国艾滋病诊疗指南(2021年版). 协和医学杂志, 2022, 13(2): 203-226. doi:10.12290/xhyxzz.2022-0097.
[21]	中国性病艾滋病防治协会HIV合并结核病专业委员会. 人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识. 中华传染病杂志, 2022, 40(1):6-19. doi:10.3760/cma.j.cn311365-20211105-00387.
[22]	World Health Organization. Treatment of drug-susceptible tuberculosis: rapid communication. Geneva: World Health Organization, 2021.
[23]	路希维. 注重多学科合作推进结核病整合医学发展. 中国防痨杂志, 2021, 43(2):105-106. doi:10.3969/j.issn.1000-6621.2021.02.001.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 23

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhao Jun, Yang Hongyu, Kang Xiong. Research progress on influencing factors and intervention strategies of stigma in patients with pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 364-369.
[2]	. [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 376-378.
[3]	. [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 379-380.
[4]	Liang Yaping, Wang Zhuo, Liu Jiayun, Zhu Lei, Li Jing, Li Meng, Wu Qianhong. Clinical trial study of a Chinese domestic tuberculous bacillus T-cell immune response detection kit [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 289-293.
[5]	Chen Yanling, Wu Di, Chen Xiuping, Lin Yujun, Chen Xiaohong. Study on the changes in lymphocyte subsets during secondary pulmonary tuberculosis dissemination and its clinical significance [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 294-304.
[6]	Lezhe Laji, He Xin, Xu Qiang, Fan Li, Cao Hongju, Sun Shanhua. Epidemiological characteristics of pulmonary tuberculosis from Meigu County,Liangshan Yi Autonomous Prefecture from 2019 to 2023 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 311-316.
[7]	Zhao Wenli, Fang Zihao, Xu Yannan, Liu Suyang, Lin Jianxiong, Chen Zhuanghao, Fu Hui, Chen Ruiming, Chang Qiaocheng. Epidemiological characteristics of tuberculosis in Na’nao County, Guangdong Province from 2005 to 2023 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 317-324.
[8]	Xia Jun. Epidemiological characteristics analysis of pulmonary tuberculosis in Shangrao City, Jiangxi Province from 2014 to 2023 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 325-332.
[9]	Cai Xiaoting, Wu Xiaoying, He Liqian, Jiang Kunhong. A study on the correlation between family doctor contract services and clinical characteristics of pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 333-338.
[10]	Li Yabo, Fan Lijuan, Sun Xiuli, Gou Liangzhi, Ren Beiying, Shi Juanzi, Wang Fang, Ma Xiaoling, Xie Yonghong, Liu Xin, Wu Qianhong. Progress in tuberculosis infection screening, diagnosis and treatment of female infertility patients before in vitro fertilization-embryo transfer [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 352-357.
[11]	Wei Jing Ru, Chen Hui, Cheng Jun. Research progress of tuberculosis screening and preventive treatment in senior high school students [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(4): 358-363.
[12]	Jiang Ruoxi, Zhong Da, Dou Xiaojie. Analysis of influencing factors on treatment failure in initially treated patients with bacterial positive pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 236-243.
[13]	Cai Xiaoting, Jiang Kunhong, He Liqian, De Hong, Wang Ting, Lai Keng, Wu Xiaoying. Analysis of the results of pulmonary tuberculosis screening among the elderly in Haizhu District, Guangzhou [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 244-248.
[14]	Yang Hongjie, Qi Fei, Zhang Hongmei, Wu Hongbo, Hu Aimin, Zhang Tongmei. Current status of diagnosis and clinical treatment on co-existent pulmonary tuberculosis and lung cancer [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(3): 273-278.
[15]	Lin Ying, Lei Yu, Zhong Miner, Du Yuhua. Construction of a new system of school tuberculosis prevention and control strategy using Delphi evaluation method [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(2): 120-127.